AzTrials
AzTrials

Glucose ToleranceNCT05300256

Peripheral Heating and Glucose Tolerance

A study testing Peripheral Heating in people with Glucose Tolerance, run by San Diego State University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Effect of peripheral heating on glucose tolerance Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Glucose Tolerance
What is being tested?
Peripheral Heating
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteUnited States
Study dates
18 Mar 2022to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18-80 years

Who cannot join

  • Open wounds on feet or legs
  • Peripheral neuropathy

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • San Diego State University

    San Diego, California, 92182

    Jeff Moore, 714-658-7215, Jmoore714@gmail.com

    Recruiting

Other trials in United States

About this study

Effect of peripheral heating on glucose tolerance

Being tested
Peripheral Heating, Sham

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Peripheral HeatingDevice

    Peripheral heating of the feet

  • ShamDevice

    Sham

Study groups in NCT05300256
Study groupRoleWhat they receive
Peripheral HeatingExperimentalPeripheral Heating
Receives: Device: Peripheral Heating
ShamSham comparatorSham
Receives: Device: Sham

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glucose concentrations

    Measured: 1 hour

Secondary outcomes (2)
  1. Insulin concentrations

    Measured: 1 hour

  2. Blood flow

    Measured: 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Mar 2022
  2. Study start18 Mar 2022
  3. Primary completion1 Dec 2024 (estimated)
  4. Study completion1 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05300256
Sponsor's protocol ID
PHTGLUCOSE
Status last verified
Apr 2024
First submitted
18 Mar 2022
Last updated
30 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Peripheral Heating in people with Glucose Tolerance, run by San Diego State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jeff Moore (7146587215, Jmoore714@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glucose concentrations (time frame: 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in